Study - Enrolling
Pediatric Vitiligo Clinical Trials
Watching your child feel different is hard. Explore pediatric vitiligo clinical trials in Arizona and see if this study could be a next step for your family.
About this study
This study is designed for children ages 2 to 12 living with vitiligo in Arizona. Researchers are evaluating the effectiveness and safety of an investigational treatment for pediatric vitiligo. Their findings could help shape more effective, targeted care for children in this age group, with close medical supervision throughout.
Who may be able to take part?
Children ages 2 to 12 with a diagnosis of vitiligo may be eligible to join this pediatric vitiligo study, subject to screening criteria. A member of the Physician Research Group (PRG) study team reviews eligibility with you and your child during the screening visit, answers your questions, and explains what each step means before anyone makes a decision.
What participation may involve?
After screening confirms eligibility, your child visits the clinic on a set schedule. At each visit, medical professionals check overall health, evaluate the skin, and track any reactions to the study treatment. The team supports your family throughout, and taking part may help move a pediatric vitiligo treatment option forward.
Questions to ask the study team
Thinking about pediatric vitiligo clinical trials for your child? Bring these questions along to the study team:
How long will my child be in the study, and how often?
What side effects should I watch for in my child, and who do I call if I see any?
Will my child need to miss school, and how do clinic visits fit into daily life?
Study at a glance
Study Status
Recruiting
Age
2 Years to 12 Years
Location
Arizona
We're Here to Help!
Thinking about joining a research study but not sure where to start? We're happy to answer your questions, walk you through the process, and help you explore whether a study is right for you.
Frequently Asked Questions
-
Children between the ages of 2 and 12 years with vitiligo may be eligible to participate, subject to screening criteria.
-
Participation includes scheduled clinic visits where medical professionals will monitor your child’s health, assess their skin, and observe how they respond to the study treatment. The research team closely supervises each visit to ensure safety and comfort throughout the trial.
-
Child safety is a top priority in this pediatric vitiligo study. The investigational treatment is carefully monitored, and children receive close medical supervision during the trial. Parents and guardians are kept informed and can reach out to the study team with questions at any point.